4451 - 4475 of 6458 Results
Title
Year
-
OPENTitle: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotypeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 10Start Page: 714End Page: 721Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.447Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.447Citation Count: 15
-
OPENTitle: Infrared nanoimaging of neuronal ultrastructure and nanoparticle interaction with cellsJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 12Start Page: 6190End Page: 6198Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d3nr04948eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2024/nr/d3nr04948eCitation Count: 5
-
OPENTitle: RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunctionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 196Issue #:Start Page: 106514End Page: 106514Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106514Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106514Citation Count: 12
-
OPENTitle: Polymerization of Oxidized DJ-1 via Noncovalent and Covalent Binding: Significance of Disulfide Bond FormationJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 4Issue #: 6Start Page: 9603End Page: 9614Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acsomega.9b00324Best OA location URL: https://doi.org/10.1021/acsomega.9b00324Citation Count: 4
-
OPENTitle: Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and olderJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 280End Page: 280Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01095-9Best OA location URL: https://www.nature.com/articles/s41531-025-01095-9.pdfCitation Count: 4
-
OPENTitle: Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone ratsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 346Issue #:Start Page: 137End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5860948Citation Count: 4
-
OPENTitle: Spatial Image Gradient Estimation From the Diffusion MRI ProfileJournal Name: Magnetic Resonance in MedicinePublisher: WileyVol: 95Issue #: 5Start Page: 2980End Page: 2991Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mrm.70258Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mrm.70258Citation Count: 0
-
OPENTitle: Genetic and clinical study of PARK7 in Japanese Parkinson's diseaseJournal Name: HeliyonPublisher: Elsevier BVVol: 10Issue #: 15Start Page: e35271End Page: e35271Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e35271Best OA location URL: https://doi.org/10.1016/j.heliyon.2024.e35271Citation Count: 6
-
OPENTitle: Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian AncestryJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 8Start Page: 1424End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29821Citation Count: 5
-
OPENTitle: Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian CellsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 20Start Page: 3204End Page: 3213Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.0c00300Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00300Citation Count: 7
- Substrate recognition by the human mitochondrial processing peptidase and its processing of PINK12025OPENTitle: Substrate recognition by the human mitochondrial processing peptidase and its processing of PINK1Journal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 301Issue #: 12Start Page: 110860End Page: 110860Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jbc.2025.110860Best OA location URL: https://www.jbc.org/article/S0021-9258(25)02712-7/pdfCitation Count: 2
- Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson’s disease2026OPENTitle: Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-026-01282-2Best OA location URL: https://www.nature.com/articles/s41531-026-01282-2_reference.pdfCitation Count: 2
- Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease2020OPENTitle: Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 963End Page: 976Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28424Best OA location URL: https://pub.dzne.de/record/157801Citation Count: 59
- A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease2021OPENTitle: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023Best OA location URL: http://www.prd-journal.com/article/S1353802021002431/pdfCitation Count: 42
-
OPENTitle: High-Throughput Extracellular Vesicle Isolation Using Plate-Based Size Exclusion Chromatography and AutomationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 16Start Page: 13258End Page: 13263Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jacs.4c17948Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12739687/Citation Count: 10
-
OPENTitle: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 571End Page: 582Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4315751Citation Count: 91
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: http://americanae.aecid.es/americanae/es/registros/registro.do?tipoRegistro=MTD&idBib=3333801Citation Count: 17
-
OPENTitle: Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson’s disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 2Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa369Best OA location URL: https://academic.oup.com/brain/article-pdf/144/2/e16/36454303/awaa369.pdfCitation Count: 1
-
OPENTitle: Neural closed-loop deep brain stimulation for freezing of gaitJournal Name: Brain StimulationPublisher: Elsevier BVVol: 13Issue #: 5Start Page: 1320End Page: 1322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2020.06.018Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X20301364/pdfCitation Count: 59
-
OPENTitle: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiologyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 46Start Page: eadu0726End Page: eadu0726Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adu0726Best OA location URL: https://doi.org/10.1126/sciadv.adu0726Citation Count: 3
-
OPENTitle: KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicityJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 112Issue #: 31Start Page: 9596End Page: 9601Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1505953112Best OA location URL: https://www.pnas.org/content/pnas/112/31/9596.full.pdfCitation Count: 171
- The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain2026OPENTitle: The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brainJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 18Issue #: 851Start Page: eaec0813End Page: eaec0813Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aec0813Citation Count: 0
-
OPENTitle: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian EfficacyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 6Start Page: 1134End Page: 1142Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30175Citation Count: 12
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 12
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 115